X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (430) 430
Publication (27) 27
Book Review (6) 6
Book Chapter (4) 4
Conference Proceeding (3) 3
Magazine Article (2) 2
Patent (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (195) 195
oncology (178) 178
female (165) 165
index medicus (146) 146
breast cancer (123) 123
middle aged (97) 97
aged (96) 96
adult (81) 81
breast neoplasms - drug therapy (79) 79
cancer (70) 70
breast neoplasms - pathology (65) 65
chemotherapy (58) 58
prognosis (51) 51
hematology, oncology and palliative medicine (46) 46
treatment outcome (45) 45
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
aged, 80 and over (41) 41
male (38) 38
research (37) 37
care and treatment (36) 36
survival analysis (33) 33
analysis (32) 32
metastasis (31) 31
carcinoma (29) 29
chemotherapy, adjuvant (28) 28
breast neoplasms - metabolism (26) 26
neoplasm metastasis (25) 25
therapy (25) 25
adjuvant chemotherapy (23) 23
antineoplastic agents - therapeutic use (23) 23
breast neoplasms - mortality (23) 23
breast neoplasms - surgery (22) 22
neoplasm staging (22) 22
obstetrics & gynecology (22) 22
survival (22) 22
women (22) 22
antineoplastic combined chemotherapy protocols - adverse effects (21) 21
disease-free survival (21) 21
medicine & public health (21) 21
risk factors (21) 21
environmental sciences (20) 20
paclitaxel (20) 20
expression (19) 19
tumors (19) 19
cancer patients (18) 18
cyclophosphamide (18) 18
docetaxel (18) 18
health aspects (18) 18
breast neoplasms - genetics (17) 17
italy (17) 17
metastatic breast cancer (17) 17
receptor, erbb-2 - metabolism (17) 17
trial (17) 17
breast neoplasms - therapy (16) 16
clinical trials (16) 16
risk (16) 16
young adult (16) 16
age factors (15) 15
breast neoplasms - diagnosis (15) 15
disease progression (15) 15
doxorubicin (15) 15
internal medicine (15) 15
randomized controlled trials as topic (15) 15
taxoids - administration & dosage (15) 15
antineoplastic agents, hormonal - therapeutic use (14) 14
combination (14) 14
hematology (14) 14
oncology, experimental (14) 14
phase-iii trial (14) 14
postmenopausal women (14) 14
predictive value of tests (14) 14
surgery (14) 14
toxicity (14) 14
trastuzumab (14) 14
biomarkers (13) 13
cyclophosphamide - administration & dosage (13) 13
mastectomy (13) 13
metastases (13) 13
proportional hazards models (13) 13
receptors, estrogen - metabolism (13) 13
research article (13) 13
clinical trials as topic (12) 12
drug administration schedule (12) 12
efficacy (12) 12
elderly (12) 12
estrogen (12) 12
follow-up studies (12) 12
immunohistochemistry (12) 12
multicenter (12) 12
open-label (12) 12
patients (12) 12
recurrence (12) 12
tamoxifen (12) 12
usage (12) 12
adolescent (11) 11
aged patients (11) 11
anthracyclines (11) 11
antineoplastic agents - adverse effects (11) 11
biology (11) 11
breast-cancer (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_5
Abstract Background HER2 blockade in combination with chemotherapy (CT) remains the treatment of choice for patients with early HER2+ BC, irrespective of ER... 
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2018, Volume 29, Issue 8, pp. 1634 - 1657
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2328 - 2333
Abstract Background Chemotherapy plus 1-year trastuzumab is the standard adjuvant treatment of HER2-positive breast cancer. The efficacy of less extended... 
Adjuvant | Breast cancer | De-escalated treatment | Trastuzumab | Cardiac safety | trastuzumab | STAGE BREAST-CANCER | de-escalated treatment | ONCOLOGY | adjuvant | DOXORUBICIN | breast cancer | OPEN-LABEL | DOCETAXEL | cardiac safety | PACLITAXEL | Anthracyclines - adverse effects | Antineoplastic Agents, Immunological - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cardiotoxicity - epidemiology | Cardiotoxicity - etiology | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Time Factors | Chemotherapy, Adjuvant - adverse effects | Mastectomy | Adult | Female | Taxoids - adverse effects | Drug Administration Schedule | Chemotherapy, Adjuvant - standards | Neoplasm Recurrence, Local | Trastuzumab - adverse effects | Trastuzumab - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Agents, Immunological - adverse effects | Antineoplastic Combined Chemotherapy Protocols - standards | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Breast Neoplasms - mortality | Bridged-Ring Compounds - adverse effects | Aged | Neoplasm Staging | Bridged-Ring Compounds - administration & dosage
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, p. v217
Journal Article
Science of the Total Environment, ISSN 0048-9697, 08/2015, Volume 524-525, pp. 361 - 375
Waste electrical and electronic equipment (WEEE) is one of the fastest growing waste streams in Europe, whose content of hazardous substances as well as of... 
Material recovery | WEEE | LCA | RECOVERY | ENVIRONMENTAL SCIENCES | METALS | TOXICITY | IMPACTS | FRESH-WATER | Metals | Electronics | Italy | Conservation of Natural Resources | Plastics | Electronic Waste | Household Articles | Waste Management - methods | Electronic waste | Home appliances | Electronic equipment and supplies | Analysis | Index Medicus
Journal Article